Screener
Roivant Sciences ROIV EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Roivant Sciences’s reported figures.
Based on trailing twelve months.
The source filing: Roivant Sciences’s 10-Q, filed February 6, 2026. Open the filing →
- Filed
- Feb 6, 2026, 7:31 AM EST
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q4 2025
- Accession
- 0001635088-26-000011
FAQ
- What is Roivant Sciences's EBITDA margin?
- Roivant Sciences (ROIV) reported EBITDA margin of -9,099.5% in Q4 2025.
- How has Roivant Sciences's EBITDA margin changed year-over-year?
- Roivant Sciences's EBITDA margin decreased by 296.3% year-over-year, from -2,296.4% to -9,099.5%.
- What is the long-term trend for Roivant Sciences's EBITDA margin?
- Over 2 years (2022 to 2024), Roivant Sciences's EBITDA margin has grown at a 11.9% compound annual growth rate (CAGR), from -2,720.3% to -3,404.9%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Roivant Sciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude